Jounce Therapeutics, Inc. 3 SEC Filings

Filed On	Filing
05 May 2023	Form 3: Concentra Biosciences, Llc, 10% owner and 1 other Holds 36,367,727 shares of Common Stock
14 Mar 2023	Form 3: Tang Kevin C, 10% owner and 2 others Holds 5,214,100 shares of Common Stock
15 Sep 2021	Form 3: Raythatha Jigar, Director No securities owned
12 Feb 2021	Form 3: Salter-Cid Luisa, Director No securities owned
26 Oct 2020	Form 3: Gilead Sciences Inc, 10% owner Holds 5,539,727 shares of Common Stock
23 Jan 2020	Form 3: Iannone Robert, Director No securities owned
21 Dec 2017	Form 3: Cole Hugh M, Chief Business Officer
23 Oct 2017	Form 3: Diaz Luis, Director No securities owned
26 Jan 2017	Form 3: Kamen Robert, Director Holds 60,975 shares of Common Stock
26 Jan 2017	Form 3: Duncan Barbara Gayle, Director
26 Jan 2017	Form 3: Higgons John Duncan, Director Holds 20,325 shares of Common Stock
26 Jan 2017	Form 3: Karsen Perry A, Director
26 Jan 2017	Form 3: Murray Richard /CA/, Director
26 Jan 2017	Form 3: Drapkin Kimberlee C, CFO and Treasurer Holds 6,775 shares of Common Stock
26 Jan 2017	Form 3: Trehu Elizabeth, Chief Medical Officer
26 Jan 2017	Form 3: Hadley Harbor Master Investors (Cayman) L.p., 10% owner Holds 0 shares of No securities are benefically owned
26 Jan 2017	Form 3: Tepper Robert I, Director Holds 542,005 shares of Common Stock
26 Jan 2017	Form 3: Pfeffer Cary, Director Holds 0 shares of Common Stock
26 Jan 2017	Form 3: Third Rock Ventures II, L.p., 10% owner and 7 others Holds 542,005 shares of Common Stock
26 Jan 2017	Form 3: Celgene Switzerland Llc, 10% owner and 1 other

Comments